-- UCB First-Half Earnings Rise 9.6%, Beating Analyst Estimates; Sales Climb
-- John Martens
-- 2010-08-02T05:10:54Z
-- http://www.bloomberg.com/news/2010-08-02/ucb-first-half-profit-increases-to-521-million-beating-analyst-estimates.html

          
          
             UCB SA, Belgiumâ€™s biggest drugmaker,
reported first-half earnings before interest, tax, depreciation,
amortization and one-time items rose to 398 million euros from
363 million euros, according to a statement on its website.
Analysts had seen Ebitda ex-items of 381.4 million euros. Sales
rose to 1.64 billion euros from 1.6 billion euros.  
          
          


  


        